Maiti, A., DiNardo, C. D., Daver, N. G., Rausch, C. R., Ravandi, F., Kadia, T. M., . . . Konopleva, M. Y. (2021). Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia. Blood Cancer J.
Dyfyniad Arddull ChicagoMaiti, Abhishek, et al. "Triplet Therapy With Venetoclax, FLT3 Inhibitor and Decitabine for FLT3-mutated Acute Myeloid Leukemia." Blood Cancer J 2021.
Dyfyniad MLAMaiti, Abhishek, et al. "Triplet Therapy With Venetoclax, FLT3 Inhibitor and Decitabine for FLT3-mutated Acute Myeloid Leukemia." Blood Cancer J 2021.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.